<DOC>
	<DOCNO>NCT02211885</DOCNO>
	<brief_summary>Study characterize pharmacokinetics 14C-radiolabeled BIRB 796 BS metabolite include excretion mass balance parent compound radioactivity ; isolate , identify quantify major radiolabeled metabolite BIRB 796 plasma , urine feces</brief_summary>
	<brief_title>Excretion Balance 14c-radiolabeled BIRB 796 BS Normal Male Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male subject determine result screen . Health confirm medical history , physical examination , laboratory test 12lead electrocardiogram ( ECG ) Signed write informed consent accordance Good Clinical Practice Age ≥ 18 ≤ 45 year Subjects within 10 % normal height : weight range define Metropolitan Life Insurance Company Tables Any find medical examination ( include blood pressure , pulse rate , ECG ) deviate normal clinical relevance History clinically significant disease include metabolic , endocrinologic , immunological , hepatic , renal , gastrointestinal , respiratory , cardiovascular , psychiatric neurological History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Subjects history drug abuse alcoholism Chronic relevant acute ( within 1 month screen ) infection Subjects take prescription within one month overthecounter drug within two week start trial Participation another trial investigational drug ( ≤ 2 month prior administration trial ) Inability refrain smoke trial day Blood donation &gt; 400 mL ( within 1 month prior administration trial ) Any laboratory value outside 10 % reference range clinical relevance ( exclusive ) total white cell count ≥ 10 x 10**9/L , hemoglobin &lt; 12 mg/dl &gt; 15 mg/dl . Protein urine dipstick Positive urine drug screen , positive HIV Hepatitis C antibodies History familial bleeding disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>